Another noteworthy publication to which C3G members contributed as authors was published in Nature Immunology this summer. An important focus of the study was the comparison of HIV-specific CD4 T-cells subpopulations from patients who have undergone antiretroviral therapy and patients who spontaneously suppress HIV viral load below detectable limits (a.k.a. elite controller patients). This comparison contributes to an understanding of why viral control is lost once antiretrovial activity therapy is interrupted.
Altered differentiation is central to HIV-specific CD4
Share this post on social media:
Facebook
X
Linkedin
Recent Posts
- A beginner’s Guide to Manual Curation of Transposable Elements
- C3G Bioinformatics Platform at the Rosalind and Morris Goodman Cancer Institute
- The SecureData4Health (SD4H) website is LIVE
- Gene fusion meta-calling with MetaFusion
- Working with Genomics Coming From a Pure Software Engineering Background
- Understanding why persons living with HIV are at increased risk of tuberculosis
- Whole Genome STR Analysis
- A small number of early introductions seeded widespread transmission of SARS-CoV-2 in Quebec, Canada